Publications & Talks
Our Research / Publications & Talks
ALS Therapy Development: Challenges and Opportunities.
Benatar M (invited speaker). ALS Therapy Development: Challenges and Opportunities. ALS Association Wisconsin Chapter. Milwaukee, WI, May 2014.
Pre-symptomatic loss of cerebral white matter integrity in those at genetic risk of amyotrophic lateral sclerosis.
Turner M (presenter), Filippini N, Govind V, Andersen PM, Stanislaw C, Reyes E, Hussain S, Wuu J, Benatar M. Pre-symptomatic loss of cerebral white matter integrity in those at genetic risk of amyotrophic lateral sclerosis. Platform presentation at the American Academy of Neurology 66th Annual Meeting, Philadelphia, PA, Apr 26 - May 3, 2014.
Year in Review: ALS.
Benatar M (invited speaker). Year in Review: ALS. American Academy of Neurology 65th Annual Meeting. San Diego, CA, March 2013.
Pre-Symptomatic Studies in ALS: Rationale, Challenges and Approach.
Benatar M (invited speaker). Pre-Symptomatic Studies in ALS: Rationale, Challenges and Approach. 12th Annual Packard Center Meeting. Baltimore, MD, March 2012.
Pre-fALS: Pre-Symptomatic Studies in ALS.
Benatar M (invited speaker). Pre-fALS: Pre-Symptomatic Studies in ALS. Workshop on Biomarker Studies in Pre-Symptomatic Carriers of Familial ALS/FTD. University of Oxford, Oxford, UK, January 2012.
Identifying Biomarkers in Familial ALS.
Benatar M (invited speaker). Identifying Biomarkers in Familial ALS. ALS Association Drug Discovery Meeting. Washington, DC, March 2012.
Piecing Together the Puzzle of ALS: An Emerging Picture.
Benatar M (invited speaker). Piecing Together the Puzzle of ALS: An Emerging Picture. Beijing International Conference on Neurology. Beijing, China, June 2012.
Animal Models in ALS: The Good, the Bad and the Ugly.
Benatar M (invited speaker). Animal Models in ALS: The Good, the Bad and the Ugly. Muscle Study Group Annual Meeting. Beaver Hollow, NY, September 2011.
Tackling the Challenges of ALS: A Familial Perspective.
Benatar M (invited speaker). Tackling the Challenges of ALS: A Familial Perspective. 2009 William L. Halseth ALS Visiting Lectureship. University of Colorado School of Medicine, Aurora, CO, February 2010.
Methodological Issues in Animal Therapeutic Studies: Lessons from Other Neurological Diseases.
Benatar M (invited speaker). Methodological Issues in Animal Therapeutic Studies: Lessons from Other Neurological Diseases. NINDS Meeting on Disease Modification and Anti-Epileptogenesis. Bethesda, MD, August 2010.
Electrical impedance myography (EIM) findings in pre-symptomatic SOD1+ subjects.
Lu D, Rutkove S, Gronka S, Spieker A, Usher S, Wuu J, Andersen P, Benatar M (presenter). Electrical impedance myography (EIM) findings in pre-symptomatic SOD1+ subjects. Platform presentation at the Annual Northeast ALS Consortium Meeting, Washington, DC, Oct 27-29, 2010.
The Limitations of Animal Models of Neurodegenerative Disease.
Benatar M (invited speaker). The Limitations of Animal Models of Neurodegenerative Disease. TREAT-NMD/NIH International Conference: Bottlenecks in Translational Medicine in Inherited Neuromuscular Diseases. Brussels, Belgium, November 2009.
Randomized Placebo-Controlled Trial of Arimoclomol in SOD1 Positive Familial ALS.
Benatar M (invited speaker). Randomized Placebo-Controlled Trial of Arimoclomol in SOD1 Positive Familial ALS. ALS Association Drug Discovery Symposium. Seattle, WA, May 2009.
Phase II/III Randomized Placebo-Controlled Trial of Arimoclomol in SOD1 Positive Familial ALS.
Benatar M (invited speaker). Phase II/III Randomized Placebo-Controlled Trial of Arimoclomol in SOD1 Positive Familial ALS. Packard Center 9th Annual Meeting. Baltimore, MD, April 2009.
Panel discussant on the topic of Animal Models for Neurological Disease: Success or Lack of Success for Translation.
Benatar M (invited speaker). Panel discussant on the topic of Animal Models for Neurological Disease: Success or Lack of Success for Translation. NINDS Training and Implementation Retreat. Airlie House, Warrenton, VA, March 2009.